Cargando…

RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences

Potent antiviral RNAi can be induced by intracellular expression of short hairpin RNAs (shRNAs) and artificial microRNAs (miRNAs). Expression of shRNA and miRNA results in target mRNA degradation (perfect base pairing) or translational repression (partial base pairing). Although efficient inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying Poi, Gruber, Jens, Haasnoot, Joost, Konstantinova, Pavlina, Berkhout, Ben
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
RNA
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764431/
https://www.ncbi.nlm.nih.gov/pubmed/19656954
http://dx.doi.org/10.1093/nar/gkp644
_version_ 1782173081397100544
author Liu, Ying Poi
Gruber, Jens
Haasnoot, Joost
Konstantinova, Pavlina
Berkhout, Ben
author_facet Liu, Ying Poi
Gruber, Jens
Haasnoot, Joost
Konstantinova, Pavlina
Berkhout, Ben
author_sort Liu, Ying Poi
collection PubMed
description Potent antiviral RNAi can be induced by intracellular expression of short hairpin RNAs (shRNAs) and artificial microRNAs (miRNAs). Expression of shRNA and miRNA results in target mRNA degradation (perfect base pairing) or translational repression (partial base pairing). Although efficient inhibition can be obtained, error-prone viruses such as human immunodeficiency virus type 1 (HIV-1) can escape from RNAi-mediated inhibition by mutating the target sequence. Recently, artificial miRNAs have been shown to be potent RNAi inducers due to their efficient processing by the RNAi machinery. Furthermore, miRNAs may be more proficient in suppressing imperfect targets than shRNAs. In this study, we tested the knockdown efficiency of miRNAs and shRNAs against wild-type and RNAi-escape HIV-1 variants with one or two mutations in the target sequence. ShRNAs and miRNAs can significantly inhibit the production of HIV-1 variants with mutated target sequences in the open reading frame. More pronounced mutation-tolerance was measured for targets in the 3′ untranslated region (3′ UTR). Partially complementary sequences within the 3′ UTR of the HIV-1 RNA genome efficiently act as target sites for miRNAs and shRNAs. These data suggest that targeting imperfect target sites by antiviral miRNAs or shRNAs provides an alternative RNAi approach for inhibition of pathogenic viruses.
format Text
id pubmed-2764431
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-27644312009-10-20 RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences Liu, Ying Poi Gruber, Jens Haasnoot, Joost Konstantinova, Pavlina Berkhout, Ben Nucleic Acids Res RNA Potent antiviral RNAi can be induced by intracellular expression of short hairpin RNAs (shRNAs) and artificial microRNAs (miRNAs). Expression of shRNA and miRNA results in target mRNA degradation (perfect base pairing) or translational repression (partial base pairing). Although efficient inhibition can be obtained, error-prone viruses such as human immunodeficiency virus type 1 (HIV-1) can escape from RNAi-mediated inhibition by mutating the target sequence. Recently, artificial miRNAs have been shown to be potent RNAi inducers due to their efficient processing by the RNAi machinery. Furthermore, miRNAs may be more proficient in suppressing imperfect targets than shRNAs. In this study, we tested the knockdown efficiency of miRNAs and shRNAs against wild-type and RNAi-escape HIV-1 variants with one or two mutations in the target sequence. ShRNAs and miRNAs can significantly inhibit the production of HIV-1 variants with mutated target sequences in the open reading frame. More pronounced mutation-tolerance was measured for targets in the 3′ untranslated region (3′ UTR). Partially complementary sequences within the 3′ UTR of the HIV-1 RNA genome efficiently act as target sites for miRNAs and shRNAs. These data suggest that targeting imperfect target sites by antiviral miRNAs or shRNAs provides an alternative RNAi approach for inhibition of pathogenic viruses. Oxford University Press 2009-10 2009-08-05 /pmc/articles/PMC2764431/ /pubmed/19656954 http://dx.doi.org/10.1093/nar/gkp644 Text en © 2009 The Author(s). Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle RNA
Liu, Ying Poi
Gruber, Jens
Haasnoot, Joost
Konstantinova, Pavlina
Berkhout, Ben
RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences
title RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences
title_full RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences
title_fullStr RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences
title_full_unstemmed RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences
title_short RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences
title_sort rnai-mediated inhibition of hiv-1 by targeting partially complementary viral sequences
topic RNA
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764431/
https://www.ncbi.nlm.nih.gov/pubmed/19656954
http://dx.doi.org/10.1093/nar/gkp644
work_keys_str_mv AT liuyingpoi rnaimediatedinhibitionofhiv1bytargetingpartiallycomplementaryviralsequences
AT gruberjens rnaimediatedinhibitionofhiv1bytargetingpartiallycomplementaryviralsequences
AT haasnootjoost rnaimediatedinhibitionofhiv1bytargetingpartiallycomplementaryviralsequences
AT konstantinovapavlina rnaimediatedinhibitionofhiv1bytargetingpartiallycomplementaryviralsequences
AT berkhoutben rnaimediatedinhibitionofhiv1bytargetingpartiallycomplementaryviralsequences